The identification of the link between VitB6 and metabolic syndrome including insulin and NAFLD might help to define novel nutritional and pharmacological approaches for the treatment of diabetes, obesity, and insulin resistance. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.